By Oliver Gray Investing.com - The S&P/ASX 200 lost 4.7 points or 0.1% to 7,141.6 during Tuesday’s trading session, extending losses of 0.2% on Monday and closing below 8-week...
By Oliver Gray Investing.com - The S&P/ASX 200 was down 10.4 points or 0.2% at 7,135.9 after 80 minutes of Tuesday’s trade, extending declines of 0.2% in the previous session as...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Originally published by AMP Capital Investment markets and key developments over the past week Global shares were flat to down over the past week not helped by weak economic data...
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
|Average||3450.46 (+10706.33% Upside)|
|No. of Analysts||13|